Progressive Supranuclear Palsy

The latest sourced reporting on Progressive Supranuclear Palsy from Dementias Today: dated, and plain about what the evidence does and does not show.

Tau's escape route out of the lysosome, and the crew that tries to seal it

A new preprint from a Berkeley structural biology lab used cryo-electron tomography on cultured neurons and astrocytes and found no evidence that tau fibrils tear their way out of lysosomes. The compartments stayed intact. The leak, the authors argue, is something subtler. This is laboratory cell work, not peer reviewed, and not a treatment.

Model puts blood marker first in sporadic frontotemporal syndromes

A data-driven cascade model in 489 patients with bvFTD, primary progressive aphasia, progressive supranuclear palsy, corticobasal syndrome and FTD-ALS places plasma GFAP first and steep clinical decline last. The work is observational and its authors present it as a framework for staging and trial design, not as a test for any individual.

The Trial Nobody Can Afford, And The Scan That Might Shrink It

A model trained on autopsy-confirmed brains was used to pick participants for imaginary trials in progressive supranuclear palsy and corticobasal degeneration. On paper, the numbers needed fell by half for PSP and by 87 percent for CBD. The trials are still imaginary.